ALKERMES | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.29B 562M 2025-03
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
ALKERMES USD 171.7M 24.71M 2025-03
Amgen USD 1.69B 191M 2025-03
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
J&J USD 5.11B 1.34B 2025-03
Malin Corporation EUR 700K 1.6M 2024-06
Merck USD 2.53B 319M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Otsuka Holdings JPY 232.5B 30.8B 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



ALKERMES 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.